Litigation Details for TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)
✉ Email this page to a colleague
TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-01-24 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | |
| Patents | 6,977,257; 7,560,445; 7,977,324; 8,512,967; 8,980,878; 9,801,977 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-04-06 | 63 | Opinion | 7,560,445 (“the ’455 patent”), 7,977,324 (“the ’324 patent”), 8,039,657 (“the ’657 … 1 patent”), and 8,536,155 (“the ’155 patent”) (collectively, the “patents-in-suit”). Pls.…53 of the ’445 patent, Claims 20, and 31 of the ’324 patent, Claim 28 of the ’657 patent, and Claim 18…implication.” Dow Chem. Co. v. Sumitomo Chem. Co., 257 F.3d 1364, 1373 (Fed. Cir. 2001). Indeed, if the …implication.” Dow Chem. Co. v. Sumitomo Chem. Co., 257 F.3d 1364, 1373 (Fed. Cir. 2001). In the instant | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
